Phillips-Medisize strengthens its presence in Europe through integration of Medicom A/S, Denmark

elektronisches/digitales Autoinjectorsystem / electronic auto injector system for pharma client

INNOVATIVE SOLUTIONS: Phillips-Medisize will present solutions for development and manufacture of medical devices in drug delivery, consumable diagnostics, and medical/surgical consumable technologies at COMPAMED in Dusseldorf, Germany, 14-17 November 2016 (hall 8a, stand H15). The wide variety of contract services featured include device strategy, product development and manufacture across specialty drug delivery devices, dosing systems, disposables and consumables for diagnose components, disposable insulin pens, blood glucose meters, inhalators, multi-component dosing units, spray applicators, IV sets, peristaltic pumps, titration plates, mixing injectors, right up to complete MDD application sets. Phillips-Medisize offers its customers a complete service chain, from first ideas to finished solutions, from the design stage all the way to the ready-to-use sterile-wrapped medical products. The company’s strong point in the market is represented in particular by complex disposables, controlled across all processes through highly prioritized quality assurance measures compliant with ISO 13485 as well as FDA standards and GMP (Good Manufacturing Practice). Highlights among the showcased examples of developments are wearable drug delivery devices which considerably ease insulin dosing and delivery.

Phillips-Medisize is always focused on quality, innovation and service. Successful and prosperous partnership with customers is based on process know-how, state-of-the art hardware and, last but not least, investment in qualified personnel. As the worldwide leading outsource partner for the design and production of medical and pharmaceutical devices Phillips-Medisize has once again extended its presence in Europe considerably in order to take account of the rising demand for biopharmaceutical and medical drug delivery systems. On June 1st, 2016, Phillips-Medisize announced the acquisition of Medicom Innovation Partner A/S, Struer, Denmark, including Medicom’s subsidiary in Cambridge, UK. This leading provider of medical devices with a focus on product strategy and development of personal connected health drug delivery devices has grown continuously and employs a staff of 90 specialists in Denmark and the UK. Philipp-Medisize now employs about 500 engineers throughout its global design and development network with hubs in Struer, Denmark and Hudson, WI, USA to develop injectable and inhalation device innovations for global market.

The fundamental motives for acquisitions are deeply rooted in Phillips-Medisize’s corporate strategy:

- to incorporate companies with high competence, culture and reputation in the medical device and pharmaceutical markets,
- to partner small and medium-sized expert firms with comparable engineering know-how – both for their qualified personnel, as well as their comprehensive plastics processing machinery
- to expand together with partners whose product program is a valuable complement to Phillips-Medisize’s portfolio, and
- to enlarge the company’s footprint in the respective markets.

For Phillips-Medisize, this transaction of acquiring Medicom is completely in line with the company’s strategic focus on serving the rapidly growing market segments of diabetes and biologics treatments, as well as pharmacological and personalized oncology solutions. These markets need advanced products. Furthermore, the increased volume and wider program significantly reinforces its leading position in the segment of drug delivery devices. Customers of both companies will benefit from the comprehensive portfolio of integrated end-to-end services and obtain the expected prime quality supported by a worldwide service network.